Evidence map›Paper›PMID 41996113›Full record

ArticleJAMA network open2026

Maternal Circulating sFlt-1:PlGF Ratio and Stillbirth.

Mi-Sun S Lee, Ki-Do Eum, David C Christiani

Abstract read
In one paragraph

Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mi-Sun S LeeDepartment of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Ki-Do EumAriadne Labs, Brigham and Women's Hospital and Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
David C ChristianiDepartment of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.

Funding

Translational Research Support CoreP30ES000002 · NIEHS · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI JAIME ELIZABETH HART · 1985 to 2026
$44.6M
NIEHS NIH HHS P30 ES000002
6 · The paper itself

Abstract

Importance: Stillbirth remains a major global health challenge, particularly in low- and middle-income countries. Angiogenic imbalance, characterized by elevated soluble fms-like tyrosine kinase-1 (sFlt-1) and reduced placental growth factor (PlGF), is implicated in placental dysfunction, yet few studies have examined the association between the sFlt-1:PlGF ratio and stillbirth. Objective: To investigate the association between maternal circulating sFlt-1:PlGF ratio, using clinically relevant cutoffs, and risk of stillbirth. Design, Setting, and Participants: This case-control study included participants from 2 health clinics operated by the Dhaka Community Hospital Trust in rural Bangladesh. Pregnant women aged 18 years or older with ultrasonography-confirmed singleton pregnancies were enrolled before or at 16 weeks' gestation between March 1, 2008, and July 30, 2011. Those delivering stillborn infants (cases) were matched 1:2 with participants in the same cohort who delivered full-term live-born infants (controls). Data were analyzed between September 1, 2025, and January 1, 2026. Exposure: Maternal serum sFlt-1:PlGF ratio. Main Outcomes and Measures: The main outcome was stillbirth, defined as fetal death at 28 weeks' gestation or more. The association between sFlt-1:PlGF ratio cutoffs of greater than 38 and greater than 85 and stillbirth were estimated using Firth penalized logistic regression, with models adjusted using a propensity score incorporating maternal factors. Results: The analytic sample included 125 participants (mean [SD] age, 22.3 [3.8] years), of whom 39 were included in the stillbirth group and 86 in the live birth control group. After adjusting for propensity score, an sFlt-1:PlGF ratio greater than 38 was significantly associated with an increased odds of stillbirth (odds ratio [OR], 13.44; 95% CI, 2.03-88.89). Similar results were observed using the cutoff of 85 (OR, 12.95; 95% CI, 1.57-106.64). Elevated sFlt-1:PlGF ratios showed high positive predictive value for stillbirth at the cutoff of 38 (88.9%; 95% CI, 51.8%-99.7%) and 85 (85.7%; 95% CI, 42.1%-99.6%). Negative predictive values were moderate at 73.3% (95% CI, 64.3%-81.1%) and 72.0% (95% CI, 63.0%-79.9%), respectively, indicating that low ratios had a limited ability to rule out stillbirth. Conclusions and Relevance: This case-control study found that a high sFlt-1:PlGF ratio using clinically relevant thresholds was associated with stillbirth and corresponded to an estimated 13-fold increased risk. These findings suggest that angiogenic imbalance may contribute to stillbirth and highlight the potential utility of angiogenic markers as indicators of pregnancy complications in low-resource settings.

Indexed as

Placenta Growth FactorStillbirthVascular Endothelial Growth Factor Receptor-1AdultBangladeshBiomarkersCase-Control StudiesFemaleHumansPregnancyRisk FactorsYoung AdultBiomarkersFLT1 protein, humanPGF protein, humanPlacenta Growth FactorVascular Endothelial Growth Factor Receptor-1

Identifiers

PMID41996113
PMCPMC13090853

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.